AzTrials
AzTrials

Hospital Readmissions of Elderly PatientsLASUITENCT05814328

Geriatric Transitional Care for Older Patients Discharged From the Emergency Department: Impact on Early Readmissions

A study testing Transitional Care in people with Hospital Readmissions of Elderly Patients, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Elderly adults have high rates of emergency department (ED) visits. Specificities of this population challenge organizations of care in the ED, and older adults are at risk of pejorative outcomes after an ED stay. Read more about this study

Who is it for?
Ages 75 years and older
What is being tested?
Transitional Care
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,322 participants
Where
1 siteFrance
Study dates
4 Mar 2025to Feb 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 75 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Patient admitted to the emergency departement over 75 years old and living at home (including independent residence)
  • Patient admitted to the Emergency Reception Service (ERS) for less than 48 hours for whom a return home has been decided
  • Identified at risk of readmissions to the emergency departement with a Triage Risk Screening Tool (TRST) score > 2.
  • Consent to the study possible at the time of his visit to the emergency room by the patient or a caregiver present at the time of inclusion.
  • Patient affiliated with a social security (beneficiary or partner)

Who cannot join

  • Person living in an nursing home
  • Severe cognitive impairment according to DSM V criteria and absence of a close relative at the time of inclusion
  • Unstabilized psychiatric pathology and absence of relatives at the time of inclusion
  • Language barrier and absence of relatives at the time of inclusion
  • Person under guardianship, under legal safeguard measure, deprived of liberty by judicial or administrative decision, persons subject to psychiatric care without their consent, persons admitted to a health or social establishment for purposes other than those of the research
  • Patient under state medical assistance
  • Patient already included in the research

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Claire Patry, MD PHD contact

33153111821

claire.patry@aphp.fr

Manuel Sanchez, MD PHD contact

33140257089

manuel.sanchez@aphp.fr

France1 site, 1 recruiting
  • Bichat Hospital

    Paris, 75018

    Claire Patry, MD PHD, 33153111821, claire.patry@aphp.fr

    Manuel Sanchez, MD PHD, 33140257089, manuel.sanchez@aphp.fr

    Recruiting

Other trials in France

About this study

Elderly adults have high rates of emergency department (ED) visits. Specificities of this population challenge organizations of care in the ED, and older adults are at risk of pejorative outcomes after an ED stay. Numerous interventions have been designed to improve quality of care and outcomes for the older population in these settings, with a specific attention to concerning discharge from the ED. These interventions are interdisciplinary, bridging emergency and geriatric care. The wide range and complexity of these interventions make them difficult to assess and compare, as highlighted by several reviews in the past ten years. Prior analyses helped to categorize different intervention strategies and three main designs: inhospital, community and transitional interventions started in the ED and pursued in collaboration with community primary care professionals . Theses analyses show that the use of multiple strategies and transitional models of care tend to lead to better outcomes, and underline that more robust studies are needed to confirm this hypothesis. In France a majority of EDs collaborate with Geriatric Mobile Teams (GMT) to improve quality of care for older patients. GMTs are dedicated to patients over 75 years old, and interventions in EDs are targeted on patients at risk of worse outcome. When ED physicians detect older patients at risk they may call for the GMT for further assessment and management. GMTs either work in a inhospital standard approach or with a transitional care management. This second strategy, less common in France, is thought to be be efficient and has never been assessed. We have designed a study to compare these methods, with the hypothesis that among at-risk older adults, hospital-community transition care initiated by GMTs during an ED visit with direct discharge home will be associated with a reduction in the risk of early readmission within 30 days, and lower risk of loss of independence at 3 and 6 months. It is a french multicentric study, with a quasi-experimental design, comparing hospitals without transitional care management to hospitals with hospital-community transitional intervention. We aim at enrolling 1322 patients aged 75 and more at risk of pejorative outcomes as determined by the Triage Risk Screening Toll (TRST). The main outcome is a revisit to the ED between day 7 and day 30, secondary outcomes are autonomy, mortality, use of hospital services and caregiving at home at 6 months.

Read the detailed description

The aim of this study is to evaluate the impact of transitional care initiated by Mobile Geriatrics Team (MGTs) at the time of the ED visit on the incidence of early readmissions, on medical journey and autonomy within 6 months after the ED visit, for adults aged 75 or older and considered at risk for early readmission. This is a multicenter, prospective, controlled, non-randomized quasi-experimental study. Inclusion criteria are age 75 years and more, returning home after an ED visit, with a Triage Risk Screening Tool (TRST) score ≥ 2. Exclusion criteria are living in nursing home, being under legal guardianship or incapacity to consent. All participants will provide a written consent after receiving oral and written information. Participants with language barrier, severe cognitive or psychiatric disorders may be included provided that a relative is physically present at the time of the ED visit. Otherwise they will not be included. The study protocol has been submitted for approval to the ethic committee. Five centers (two university hospitals, three regional hospitals) work on an in-hospital strategy and do not perform transitional care. After identifying the patient at risk, the in-hospital MGT solely provides usual recommendations at the time of the ED visit, without offering home-based intervention or coordination with community actors. The participants included in these centers will form the control group.

Seven centers (three university hospitals, four regional hospitals) work on an transitional care method. These centers have an in and out-hospital MGT that carry out geriatric assessment, offer home-visits if necessary, and have a hospital-community coordination for the management of older patients. This coordination is defined by either regular joint clinical meetings, joint visits, shared professionals, or a shared information system. After identification of the at-risk patient, the first step in management consists in a telephone call by the GMT to the patient or his family and primary care professionals within six days of his return home. Depending on the geriatric assessment performed and the coordination organization specific to each center, multidisciplinary interventions can then be proposed and deployed. The patients included in these centers will form the intervention group.

All 12 centers (intervention and control) meet the following criteria for a standardized in-hospital management during the ED visit, including (i) identification of patients at risk based on clinical characteristics or identification scores with a procedure for reporting to the in-hospital GMT; (ii) a multidisciplinary GMT mobilized in the ED for patients at risk providing a standardized geriatric assessment; (iii) a discharge procedure with at least a medical report and referral to the general practitioner.

The principal investigator and the scientific committee will regularly verify that centers continue to meet the conditions of the group it is allocated.

After inclusion, the participants will benefit from the usual care specific to the inclusion center where they were recruited. In the intervention group, GMT intervention initiation consists in an early, standardized telephone call between D1 and D6 for each participant. To respect a pragmatic approach, the intervention of the MGT and the out-of-hospital management strategy are deliberately not standardized in order to evaluate the hospital-community coordination fitting each territory .

Clinical data will be collected at baseline and during follow-up at three (M3) and six (M6) months (Figure 1). The data collected at baseline during the ED visit (D1) by the MGT. This evaluation will be based on the patients' questioning and the medical record. If deemed necessary, the GMT may also rely on information transmitted by a relative or the general practitioner in order to cross-check the information, as is done routinely. The data relative to socio demographic items are age, sex; autonomy in the week prior to the ED visit using the Activities of Daily Living (ADL) and Instrumental Activities of Daily Living (IADL) scales (18,19), self-reported difficulty related to housing, identification of relatives, family and professional caregivers preexisting the ED visit; the nutritional risk using the Mini Nutritional Assessment - Short form (MNA-SF) scale in its alternative version with measurement of calf circumference (20); the screening for cognitive disorders with the Abbreviated Mental Test 4 (AMT4) scale (21) and suggestive clinical diagnosis in the mild, moderate or severe stage, according to the 5th edition of the Diagnostic and Statistical manual of Mental disorders (DSM-V) criteria; the comorbidity level assessed the Charlson index (22) and the number of drugs in the patient's usual treatment; data on the ED visit that including duration the visit in hours and main diagnosis collected from medical records; the history of ED visits or hospitalizations in the previous month and the existence of a regular medical monitoring by the general practitioner (twice a year) or a geriatric team (previously hospitalized in a geriatric wards or appointment with a geriatrician).

One independent investigator will perform follow-up telephone interviews in both groups at M3 and M6 to precise the vital status, place of living (home, nursing home), ADL and IADL, interventions of professional and non-professional caregivers. In addition for participants in the intervention group the independent investigator will identify at M6 the MGT's actions after discharge from ED based on the MGT's medical record including the number and duration of telephone calls and home visits, the coordination with community professionals (medical appointment, rehabilitation care, request for social worker).

The primary endpoint will be the incidence of readmission to an ED between seven (D7) to thirty (D30) days after discharge from the ED visit leading to inclusion in the study, regardless of the reason for admission. This data will be collected from the National Health Data System (NHDS), thus allowing the identification of admissions to an ED on a national level and not exclusively in the centers participating in the research. Very early readmissions (from D1 to D6) will not be taken into account in the primary endpoint, as the time to first intervention in interventional group is a maximum of six days in the framework of the research protocol. Moreover, these very early readmissions are most often motivated by a rapid deterioration of the initial pathology, a diagnostic error or a possible side effect of a therapy (23). Hospital-community transitional care is not intended to avoid this type of very early readmission. The ED visits between D1 and D6 and after D30 will be collected in NHDS as secondary endpoints. The number of ED visits, unplanned hospitalizations and the time duration between inclusion and the first outcome will be also considered.

Being tested
Transitional Care
Keywords
Emergency, Elderly Patients, Geriatrics, transitional Care
Medical subject headings
Emergencies

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Transitional CareOther

    Targeted inhospital intervention of GMT for patient aged 75 ans more with TRST score ≥2 with a follow-up after ED discharge. Transitional Care is defined by a geriatric team having intervention strategies linked to community care: home visits with community professionals and/or multidisciplinary clinical meetings and/or shared professionals and/or shared information systems.

Study groups in NCT05814328
Study groupRoleWhat they receive
Standard CareNo interventionTargeted inhospital intervention of GMT for patient aged 75 ans more with TRST score ≥2
Transitional CareExperimentalTargeted inhospital intervention of GMT for patient aged 75 ans more with TRST score ≥2 with a follow-up after ED discharge. Transitional Care is defined by a geriatric team having intervention strategies linked to community care: home visits with community professionals and/or multidisciplinary clinical meetings and/or shared professionals and/or shared information systems.
Receives: Other: Transitional Care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Revisits to an emergency Department

    Measured: From Day 7 to day 30

Secondary outcomes (34)
  1. Delay to the first revisit to an ED

    delay between ED discharge and the first revisit to an ED in days

    Measured: day 7 to 6 months

  2. Cumulated time of hospitalization

    number of days of hospitalization from day 7 to 6 months

    Measured: day 7 to 6 months

  3. Independence evolution

    defined by the loss of 1 point on the ADL or IADL scale

    Measured: Day 0 to 3 months

  4. Informal caregiver evolution

    number of hours of weekly family caregiver presence

    Measured: Day 0 to 3 months

  5. Informal caregiver evolution

    number of hours of weekly family caregiver presence

    Measured: Day 0 to 6 months

  6. Healthcare provider evolution

    number of weekly visits of healthcare providers

    Measured: Day 0 to 3 months

  7. Healthcare provider evolution

    number of weekly visits of healthcare providers

    Measured: Day 0 to 6 months

  8. Personal care assistant evolution

    number of hours of weekly personal care assistant presence

    Measured: Day 0 to 3 months

  9. Personal care assistant evolution

    number of hours of weekly personal care assistant presence

    Measured: Day 0 to 6 months

  10. Living in a nursing home

    Number of Patients living in a nursing home

    Measured: at 3 months and 6 months

  11. Living at home

    Number of patients living at home

    Measured: at 3 months and 6 months

  12. Hospitalization

    Number of hospitalised patients

    Measured: at 3 months and 6 months

  13. Vital status

    Number of deceased patients at 3 months and 6 months

    Measured: at 3 months and 6 months

  14. Number of ED visits

    Number of ED visits recorded on national healthcare registers

    Measured: from day 7 to 6 months

  15. Number of primary care medical visits

    Number of ED visits recorded on national healthcare registers

    Measured: from day 7 to 6 months

  16. Inhospital consultations

    Number of inhospital consultations

    Measured: from day 0 to 6 months

  17. Day hospital

    Number of day hospital stays

    Measured: from day 0 to 6 months

  18. Scheduled hospitalizations in short-term care,follow-up and rehabilitation care

    Cumulative duration of stays in scheduled hospitalizations in short-term care,follow-up and rehabilitation care

    Measured: from day 0 to 6 months

  19. Nature of scheduled hospitalizations in short-term care,follow-up and rehabilitation care

    Measured: from day 0 to 6 months

  20. Unscheduled hospitalisation in short-term care, follow-up and rehabilitation care

    Cumulative duration of stays in unscheduled hospitalisation in short-term care, follow-up and rehabilitation care

    Measured: from day 0 to 6 months

  21. Nature of unscheduled hospitalizations in short-term care, follow-up and rehabilitation care

    Measured: from day 0 to 6 months

  22. Number of patients with medical follow-up

    Measured: from day 0 to 6 months

  23. Number of patient with autonomy, care or social assistance,

    Measured: from day 0 to 6 months

  24. Number of patient with personalized health plan

    Measured: from day 0 to 6 months

  25. Delay from ED to first GMT assessment

    Number of days between discharge from the ED to first GMT phone call

    Measured: from day 0 to 6 months

  26. GMT home visits

    Number of GMT home visits

    Measured: from day 0 to 6 months

  27. Contacts with patient and informal caregiver

    Number of phone calls or email contact with patient and informal caregiver for the transitional care group

    Measured: from day 0 to 6 months

  28. Contacts with primary healthcare providers

    Number of phone calls or email contact with patient and primary healthcare providers for the transitional care group

    Measured: from day 0 to 6 months

  29. Multidisciplinary GMT- community team meetings

    Number of multidisciplinary GMT- community team meetings concerning GMT patients

    Measured: from day 0 to 6 months

  30. Cumulative time of follow up

    Delay between first assesment and end of the follow up

    Measured: from day 0 to 6 months

  31. Cumulative GMT interventions

    Number of interventions of the GMT during case follow up

    Measured: from day 0 to 6 months

  32. Patient refusal

    Interruption of GMT intervention due to patient refusal

    Measured: from day 0 to 6 months

  33. Lost to follow up

    Interruption of GMT intervention due to lost of follow up

    Measured: from day 0 to 6 months

  34. description of the socio-demographic characteristics of the patients

    Measured: day 0

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Apr 2023
  2. Study start4 Mar 2025
  3. Primary completionSep 2026 (estimated)
  4. Study completionFeb 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
1,322 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05814328
Sponsor's protocol ID
210989
Other IDs
2021-A02657-34
Acronym
LASUITE
Status last verified
May 2025
First submitted
3 Apr 2023
Last updated
16 May 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Sanchez M, Eloy P, Godard V, Coutauchaud M, Lenouvel C, Charpigny M, Manchon P, Han THL, Raynaud-Simon A, Patry C. Geriatric-led transitional care for older adults discharged from the emergency department: impact on hospital readmissions and disability. Protocol for the controlled prospective quasi-experimental study LASUITE. BMC Geriatr. 2025 May 1;25(1):299. doi: 10.1186/s12877-025-05929-2.

    PubMed 40312294

Questions about this trial

What is this clinical trial studying?

A study testing Transitional Care in people with Hospital Readmissions of Elderly Patients, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 16 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Claire Patry, MD PHD (33153111821, claire.patry@aphp.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Revisits to an emergency Department (time frame: From Day 7 to day 30). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05814328, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 May 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in